Moniuszko-Jakoniuk J, Kościelak M
Pol J Pharmacol Pharm. 1976 Nov-Dec;28(6):661-5.
Bradykinin (2 mug ivc) or kallikrein (40 U/kg) inhibited the stimulatory psychomotoric action of a low (0.5 mg/kg) dose of amphetamine, and potentiated the action of a high (2 mg/kg) dose of the drug. A treatment with bradykinin and the low dose of amphetamine reduced the noradrenaline and enhanced the serotonin level in the striatum, and lowered the dopamine content in the cortex, while a combined treatment with the high dose of amphetamine elevated the dopamine level in the striatum and hypothalamus and depressed the serotonin level in the midbrain.
缓激肽(静脉注射2微克)或激肽释放酶(40单位/千克)可抑制低剂量(0.5毫克/千克)苯丙胺的刺激性精神运动作用,并增强高剂量(2毫克/千克)该药物的作用。缓激肽与低剂量苯丙胺联合治疗可降低纹状体中的去甲肾上腺素水平并提高血清素水平,同时降低皮质中的多巴胺含量,而高剂量苯丙胺联合治疗则可提高纹状体和下丘脑中的多巴胺水平,并降低中脑中的血清素水平。